Johnson & Johnson. Drug Recall Lawyer Blog. It rarely ends well.
But there is some good news for J&J. Johnson & Johnson plans to introduce four promising new drugs this year to treat: (1) AIDS, (2) prostate cancer, (3) hepatitis C and (4) strokes. The sale of these drugs should be worth billions of dollars in annual revenue.
Johnson & Johnson has been a train wreck lately. They really have. Maybe I’m just nostalgic but I really think J&J can be a great company again. Here’s hoping these drugs have been well tested and can really make a difference for patients and Johnson & Johnson.